Epidemiology of Myocardial Infarction Caused by Presumed Paradoxical Embolism via a Patent Foramen Ovale
Authors:
- 1 January 2017
- journal article
- research article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 81 (10) , 1484-1489
Abstract
Background:Despite several negative prospective randomized trials on the efficacy of patent foramen ovale (PFO) occlusion, the discussion on indications is ongoing. Because the incidence of paradoxical coronary embolism through a PFO is unknown, we investigated the risk of paradoxical embolic myocardial infarction over a period of 13 years.Methods and Results:We conducted a retrospective and a prospective study. In the former, we searched the hospital database of a tertiary referral center for cases of acute myocardial infarction (AMI) during the past 10 years and screened them for possible paradoxical MIs. On this basis we started a prospective evaluation over 39 months in another tertiary referral center. All patients with AMI and normal coronary arteries were screened for PFO and if no other reason for the AMI could be found, the case was judged as presumed paradoxical embolism. In the retrospective analysis we found 22 cases (0.45%) of presumed paradoxical coronary artery embolism under 4,848 AMI. In the prospective study there were 11 presumed paradoxical coronary artery embolisms among 1,654 patients with AMI, representing an incidence of 0.67%.Conclusions:Our findings demonstrated that well below 1% of AMIs are caused by paradoxical embolism via an interatrial communication. Although this percentage appears low, it is not a negligible number of patients based on the huge number of MIs occurring in the industrialized world.Keywords
This publication has 49 references indexed in Scilit:
- Prothrombotic Mutations as Risk Factors for Cryptogenic Ischemic Cerebrovascular Events in Young Subjects With Patent Foramen OvaleStroke, 2007
- Comparison of results of percutaneous closure of patent foramen ovale for paradoxical embolism in patients with versus without thrombophiliaThe American Journal of Cardiology, 2004
- Prothrombin G20210A Mutation, but Not Factor V Leiden, Is a Risk Factor in Patients with Persistent Foramen ovale and Otherwise Unexplained Cerebral IschemiaCerebrovascular Diseases, 2003
- Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovaleBlood Coagulation & Fibrinolysis, 2003
- Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen OvaleStroke, 2002
- Patent foramen ovale: Association between the degree of shunt by contrast transesophageal echocardiography and the risk of future ischemic neurologic eventsAmerican Heart Journal, 1996
- Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attackAmerican Heart Journal, 1995
- Atrial Septal Aneurysm in Adult PatientsCirculation, 1995
- Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography.Stroke, 1993
- Incidence and Size of Patent Foramen Ovale During the First 10 Decades of Life: An Autopsy Study of 965 Normal HeartsMayo Clinic Proceedings, 1984